Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


14.11.2022

1 Am J Respir Crit Care Med
1 Arch Bronconeumol
7 Chest
1 Eur Respir J
4 J Allergy Clin Immunol
2 J Asthma
1 PLoS One
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. FELDMAN JM, Ankam J, Barry M, Fruchter N, et al
    A Pilot RCT of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma.
    Am J Respir Crit Care Med. 2022 Nov 7. doi: 10.1164/rccm.202206-1132.
    PubMed        


    Arch Bronconeumol

  2. CALLE RUBIO M, Lopez-Campos JL, Izquierdo Alonso JL, Martinez Pitarch D, et al
    Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group.
    Arch Bronconeumol. 2022;58:776-779.
    PubMed        


    Chest

  3. CAZES N, Briquet A
    COPD Risk After Military Service: Let's Go Further Before Concluding.
    Chest. 2022;162:e287-e288.
    PubMed        

  4. SMITH KS, Lee SA, Albers BK, Stevens EL, et al
    A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation.
    Chest. 2022;162:e265-e271.
    PubMed         Abstract available

  5. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    PubMed        

  6. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    PubMed        

  7. CHO EE, Gershon AS
    Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Chest. 2022;162:947-948.
    PubMed        

  8. ALCAZAR-NAVARRETE B, Jamart L, Sanchez-Covisa J, Juarez M, et al
    Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Chest. 2022;162:1017-1029.
    PubMed         Abstract available

  9. NEDER JA, Kirby M, Santyr G, Pourafkari M, et al
    V/Q Mismatch: A Novel Target for COPD Treatment.
    Chest. 2022;162:1030-1047.
    PubMed         Abstract available


    Eur Respir J

  10. PARK JS, Cho YJ, Yun JY, Lee HJ, et al
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J. 2022;60.
    PubMed         Abstract available


    J Allergy Clin Immunol

  11. PEREZ-GARCIA J, Gonzalez-Carracedo M, Espuela-Ortiz A, Hernandez-Perez JM, et al
    The Upper-Airway Microbiome as a Biomarker of Asthma Exacerbations despite Inhaled Corticosteroid Treatment.
    J Allergy Clin Immunol. 2022 Nov 4. pii: S0091-6749(22)01475.
    PubMed         Abstract available

  12. SKEVAKI C, Chinthrajah RS, Fomina D, Rohde G, et al
    Comorbidity defines risk of asthmatics for COVID-19 hospitalization: a global perspective.
    J Allergy Clin Immunol. 2022 Nov 3. pii: S0091-6749(22)01425.
    PubMed         Abstract available

  13. STRIEKER S, Weinmann T, Gerlich J, von Mutius E, et al
    Farm living and allergic rhinitis from childhood to young adulthood - prospective results of the GABRIEL study.
    J Allergy Clin Immunol. 2022 Jun 29. pii: S0091-6749(22)00886.
    PubMed         Abstract available

  14. IRIZAR H, Chun Y, Arditi Z, Do A, et al
    Examination of host genetic effects on nasal microbiome composition.
    J Allergy Clin Immunol. 2022;150:1232-1236.
    PubMed         Abstract available


    J Asthma

  15. GUPTA S, Mukherjee A, Gupta S, Jat KR, et al
    Impulse Oscillometry (IOS) for Detection of Exercise Induced Bronchoconstriction in Children with Asthma Ages 6-15 years.
    J Asthma. 2022 Nov 6:1-15. doi: 10.1080/02770903.2022.2145219.
    PubMed         Abstract available

  16. WALID AL-QEREM, Jarab A, Abu Heshmeh SR, Ling J, et al
    Variables associated with asthma control among adult patients.
    J Asthma. 2022 Nov 6:1-14. doi: 10.1080/02770903.2022.2144351.
    PubMed         Abstract available


    PLoS One

  17. DOS SANTOS CF, Braz MG, de Arruda NM, Caram L, et al
    DNA damage and antioxidant capacity in COPD patients with and without lung cancer.
    PLoS One. 2022;17:e0275873.
    PubMed         Abstract available


    Thorax

  18. ALLAM VSRR, Pavlidis S, Liu G, Kermani NZ, et al
    Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.
    Thorax. 2022 Nov 7. pii: thorax-2021-218555. doi: 10.1136/thorax-2021-218555.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: